HKG:2511

1 story mentioning HKG:2511Updated 48d ago

Every FINWIRES story that references HKG:2511, newest first.

HighTide Therapeutics Agrees to Lend HK$15 Million to CEO

HighTide Therapeutics (HKG:2511) agreed to lend up to HK$15 million to its CEO Liu Liping, it said in a Monday Hong Kong bourse filing.The pharmaceutical company's shares fell 1% in early afternoon trade Tuesday.Borrowings under the facility are payable a year from drawdown and will accrue interest at 3.50% per annum.

HKG:2511

Track with the FINWIRES app suite

FolioX

Track HKG:2511 in your portfolio

WheelAI

Analyze HKG:2511 options with the wheel strategy

StockInsider

See market sentiment on HKG:2511